Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Disease area: Airway diseases

Abstract

Aim: To evaluate the effectiveness of pulmonary rehabilitation in patients with COPD complicated by pulmonary artery hypertension (PAH). Methods: 45 patients with COPD complicated by PAH were studied. All patients were men, mean age 65±12 years. All patients underwent clinical and laboratory examination, pulmonary function tests and echocardiography. These patients have completed pulmonary rehabilitation of six weeks. Outcome measures were breathlessness (10 point Borg scale) and exercise capacity (6MWT performed according to ATS guidelines). These measures were assessed before and after the pulmonary rehabilitation. For all the patients pulmonary rehabilitation included standard treatment with medications and supplemental oxygen, aerobic exercise training, breathing control techniques, smoking cessation program and education program. Results: We revealed significant increase in the 6MWT, distance walked passing from 210±65 m to 278±54 m (p<0.001). Also we found significant decrease in breathlessness, Borg scale score after 6MWT passing from 4.8±1.1 to 3.5±0.8 (p< 0.001). Conclusions: We conclude that pulmonary rehabilitation is effective in Russian patients with COPD complicated by PAH. We can reduce breathlessness and improve exercise capacity. Patients with COPD complicated by PAH should be included in pulmonary rehabilitation program.

Rating:

Share or cite this content

Citations should be made in the following way:
V. Pyankov, Y. Chuyasova (Kirov, Russian Federation). The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension. Eur Respir J 2009; 34: Suppl. 53, 543

Member's Comments

No comment yet.

Related content which might interest you: Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD? Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 364s Year: 2006 Pulmonary rehabilitation in patients with pulmonary arterial hypertension Source: ERS Course 2017 Year: 2017 Quality of life in Russian patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010 Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Experience with pulmonary selective vasodilator treatment in COPD with severe pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020 Year: 2020 Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160111 Year: 2017 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006